Kaempferol has been reported to act as an anti-inflammation agent in LPS-induced neuroinflammation in vitro and in vivo, but its role in the inflammation after cerebral ischemia/reperfusion (I/R) is unclear. The present study was to investigate the effect of kaempferol on inflammation in ischemic brain tissue and explore its mechanisms in cerebral I/R rats. Cerebral I/R rat model was established by middle cerebral artery occlusion for 60 min and following reperfusion. Kaempferol at doses of 25, 50 and 100 mg/kg was administered for 7 days after cerebral I/R. Kaempferol treatment significantly reduced cerebral infarct volume, attenuated inflammation and bloodbrain barrier (BBB) disruption after cerebral I/R, thus improved neurological outcomes at the day 7 after cerebral I/R. Furthermore, the results also showed kaempferol treatment decreased the phosphorylation and nuclear transposition of transcription factor NF-κB p65, thus inhibited expression of various pro-inflammatory proteins. In conclusion, kaempferol attenuates neuroinflammation and blood brain barrier dysfunction to improve neurological deficits in cerebral ischemia/reperfusion rats, its mechanism is related to NF-κB pathway.
effective therapy. Also, even though the therapy is initiated by restoring blood flow, the damage can still continue in neuron and glial cells due to reperfusion injury (Leech et al., 2019) . Therefore, controlling the pathological processes after reperfusion is important to limit neurological damage (Wicha et al., 2017; .
Many evidences suggest the damage of reperfusion in neuron and glial cells is mainly caused by inflammatory injury (Hoogland et al., 2015; Mu et al., 2016) . Many cellular events have been proposed to contribute to inflammatory process after cerebral ischemia/reperfusion (I/R), such as activation of microglia. However, the roles of microglia in the inflammatory mechanisms following cerebral I/R are not fully understood (Jiang et al., 2014; Jin et al., 2010; Lin et al., 2016; Zhan et al., 2016) .
In addition, inflammation causes mitochondrial dysfunction, reducing superoxide dismutase (SOD) activities, disturbing balance between generating and detoxifying of reactive oxygen species (ROS) (Dawson and Dawson, 2017; Goyal et al., 2017; Li et al., 2017) . Such radicals attack cell membrane lipids, proteins, and glycosaminoglycans, causing further damage (Sies et al., 2017) . Based on this information, understanding and interfering with the inflammatory process following cerebral I/R are promising to find new therapeutic strategies for cerebral ischemic stroke.
Kaempferol (3, 4, 5, 7, -tetrahydroxyflavone, KAE), a natural flavonoid in variety of plants and some of traditional medicine, has been increasingly investigated on its anti-inflammation and anti-oxidative effects (Devi et al., 2015; Rajendran et al., 2014; Yan et al., 2014) . Its anti-inflammatory effect has been reported in cultured microglia and animal inflammatory models induced by LPS Yang et al., 2019b; Park et al., 2011) . Although the anti-inflammatory effect of kaempferol is clear, its therapeutic potential and molecular mechanisms on inflammation caused by stroke remain unclear. In present study, we investigated kaempferol therapeutic effect
The TTC staining and neurological deficits scores were evaluated to investigate the protective effects of kaempferol on the ischemic brain tissues after cerebral I/R. The data showed that the infarct size of brain tissues was decreased in a dose-dependent manner by kaempferol treatment of 25 to 100 mg/kg. (Fig. 1A, 1B) . Additionally, the brain tissues in kaempferol treatment groups showed a larger proportion of ischemic penumbra, especially at the high dose of 100 mg/kg. Neurological deficits score was calculated to evaluate the protection of kaempferol on neurological function after I/R.
We chose rats exhibiting neurological deficits with the score of 1-3 at the 24 h after reperfusion for the following experiments. On the day 1, neurological deficits showed no difference among ischemic groups. On the day 7, kaempferol treatment at the dose 100 mg/kg significantly decreased neurological deficits score (Fig. 1C ).
Kaempferol attenuated microglia activation in cerebral I/R rats
Microglia is the major immune cell in the central nervous system, its activation is one of the hallmarks of neuroinflammation. We performed immunofluorescence staining to assess the effect of kaempferol on activation of microglia. Iba-1 is a marker of activated microglia and often used to characterize microglia cells, the activation of microglia cells includes the increasing in number, size and morphological change of microglia cells.
As shown in the results ( Fig. 2A) , the number and size of microglia were significantly increased in cerebral I/R group as compared to Sham group. Also, the number and size of activated microglia was decreased in a dose-dependent manner by kaempferol treatment of 25 to 100 mg/kg (Fig. 2B ). These data suggested that kaempferol treatment attenuated inflammation of ischemic brain tissues by inhibiting the microglia activation after cerebral I/R.
Effect of kaempferol on inflammatory cytokines in cerebral I/R rats
To further evaluate the effect of kaempferol treatment on inflammatory cytokines secretion, we conducted V-PLEX assays using Meso-scale Multiplex Discovery plate (Fig. 3F ), IL-4 (Fig. 3G ), IL-13 (Fig. 3H ), IL-10 ( Fig. 3I ) in I/R group as compared to sham group. Following kaempferol treatment, the elevated production of KC/GRO (Fig. 3A) , IL-5 (Fig. 3D ) were all significantly decreased at doses of 25, 50 and 100 mg/kg. While TNF-α (Fig. 3B) , IL-1β (Fig. 3C ) and IL-6 (Fig. 3E ) was decreased significantly at higher dose 100 mg/kg (Fig. 3B) .
Effects of kaempferol on the transcription and expression of iNOS and COX-2 in cerebral I/R rats
To determine whether kaempferol inhibits other pro-inflammatory proteins in addition to inflammatory cytokines, the mRNA and protein expression of iNOS and COX-2 were examined by RT-PCR and Western blotting. Compared with the Sham group, the mRNA and protein expression of iNOS and COX-2 were both significantly increased in cerebral I/R group ( Fig. 4A and Fig 4B) . Following kaempferol treatment, the expression of iNOS and COX-2 were dramatically attenuated ( Fig. 4C and Fig   4D) . These results indicated that the inhibition of iNOS and COX-2 transcription and protein expression might be one of mechanisms of kaempferol to attenuate the inflammatory response after cerebral I/R.
Cytokine profile in ischemic cerebral tissue after in cerebral I/R rats
To clarify the roles of cytokines playing in cerebral I/R, we set out a cytokine profile using the Rat Cytokine Array Q67 (RayBiotech). The above results have shown kaempferol at dose of 100 mg/kg exerts strong anti-inflammatory effect.
Therefore, 100 mg/kg kaempferol treatment was selected for further study. We measured the 67 cytokines expression in ischemic cerebral tissue from Sham, cerebral I/R, cerebral I/R+KAE-100 groups. In comparison with Sham group, 21 cytokines were found to be differently expressed in response to I/R (Fig. 5A) . Out of the 21 cytokines, 13 cytokines marked in red (Fig. 5A ) are upregulated and other 9 cytokines marked in blue (Fig. 5A ) are downregulated. From KEGG enrichment (Fig. 5B) , we
PDGF-AA after cerebral I/R (Fig. 5C ).
Effect of kaempferol on phosphorylation and nuclear translocation of NF-κB p65 in cerebral I/R rats
Microglia activation results in the activation of many signaling pathways during the inflammatory response. The above results showed that kaempferol attenuated inflammatory response in cerebral I/R rats. However, the detailed signaling pathway and its regulation mechanisms are still unclear. We performed Western blotting to measure the phosphorylation of NF-κB p65 and IκB on day 7 in Sham, cerebral I/R and cerebral I/R+100 mg/kg kaempferol treatment groups. The results showed that kaempferol treatment at dose of 100 mg/kg significantly decreased phosphorylation of NF-κB p65 (Fig. 6A ). In comparison, IκB was moderately phosphorylated in I/R group and kaempferol had less effect on IκB phosphorylation (Fig. 6B) . These results suggested kaempferol inhibits NF-κB activation by decreasing phosphorylation of NF-κB p65.
The phosphorylated NF-κB p65 can function as a transcriptional activator to increase expression of pro-inflammatory cytokines and exacerbate inflammation. To investigate translocation of NF-κB p65, we extracted nuclear protein and cytoplasm protein using nuclear-cytosol extraction kit and performed Western blotting to detect the expression of NF-κB p65 in each sample. There were only small amounts of NF-κB p65 detected in nuclear fraction in Sham group but significantly higher in I/R group (p < 0.01, Fig. 6C ). The results indicated I/R activated NF-κB signal pathway and triggered NF-κB p65 nuclear translocation from cytoplasm to nucleus. When treated with kaempferol at the dose of 100 mg/kg, the NF-κB p65 nuclear transposition was significantly blocked (p < 0.05, Fig. 6C ). In comparison, the amounts of NF-κB p65 had no significant difference in the cytoplasm fraction of Sham, cerebral I/R cerebral I/R and cerebral I/R+ kaempferol treatment groups (Fig.   6D ).
Kaempferol inhibited MMP-3 expression in ischemic cerebral tissue and decreased BBB permeability in cerebral I/R rats
Studies suggested inflammatory cytokines directly affected the permeability of
BBB and exaggerated BBB disruption. In our study, we tested BBB permeability by measuring EB leakage. The amounts of EB leakage in ischemic hemisphere significantly increased in I/R group at the day 7 after surgery. Kaempferol treatment markedly attenuated the leakage of EB in ischemic hemisphere (Fig. 7A) . The finding demonstrated kaempferol treatment protected BBB integrity, decreasing the BBB permeability in cerebral I/R rats.
Matrix metalloproteinase 3 (MMP-3) is capable of breaking down many matrix compounds and activates other MMPs. In our study, we found the expression of this matrix metalloproteinase was upregulated significantly after I/R and kaempferol treatment decreased its expression (Fig. 7B ). Kaempferol attenuated MMP-3 expression in cerebral I/R rats might be its one of the mechanisms to protect BBB integrity.
Discussion
The roles played by inflammation are changing in different stages of stroke (Dawson and Dawson, 2017) . During the acute phase, ischemic tissue secretes proinflammation cytokines rapidly, causing activation of microglia and inflammatory response. Increasing MCP-1 and ICAM-1 promote leukocytes across the BBB into brain parenchyma, releasing more pro-inflammation cytokines, which further amplify the inflammation and cause death of neurons (Jin et al., 2013) . However, in chronic phase, inflammation is regarded as a beneficial factor to tissue repair and functional recovery. Cytokines orchestrate the pathological processes in different stages after stroke (Lambertsen et al., 2012) . Accordingly, understanding mechanisms after stroke is important to find new therapeutic strategies to stroke.
In this study, we evaluated the protective effect of kaempferol to cerebral I/R injury and explored its mechanism. We found kaempferol treatment at dose 100 mg/kg reduced infarct volume and neurological deficits significantly after 7 days treatment. Then we set out a cytokine profile using protein array to explore the regulatory roles of different cytokines. From KEGG enrichment, we find the significantly regulated genes after ischemic stroke mainly enriched in immune cells differentiation and inflammatory signal pathways. This means inflammatory response still plays a key role at the day 7 after cerebral I/R.
Kaempferol was reported as an anti-inflammation agent eliciting protection to LPSinduced inflammation and microglia activation Park et al., 2011) .
It also attenuated the expression of adhesion molecules, reduced oxidative stress (Devi et al., 2015) . However, its protective effect on cerebral I/R rats have not been documented. In this study, we firstly assessed effect of kaempferol on activation of microglia after cerebral I/R. If microglia increased in number, size and changed in morphology, they were judged as activated (Hoogland et al., 2015) . In the current study, we found that kaempferol inhibited the activation of microglia after 7 days treatment in cerebral I/R rats.
Pro-inflammatory cytokines are biomarkers to evaluate extent of inflammation (Doll et al., 2014) . However, inflammatory cytokines are complicated regulatory systems and strokes include a lot of subtypes in clinical. Therefore, the prognostic value of inflammatory markers is controversial in stroke patients. Active microglia secrete lots of inflammatory cytokines such as TNF-α, IL-6, IL-1β, which orchestrates various molecular mechanisms involved in inflammation (Shabab et al., 2017) . Initial activation of microglia is beneficial to protect neurons, but excessive inflammatory cytokines led to over-activation of microglia which caused a cascade of inflammatory cytokines and uncontrolled inflammation. In our results, TNF-α, IL-6, IL-1β, IL-5, KC/GRO were increased after cerebral I/R and attenuated by kaempferol treatment.
Interestingly, we found IL-2 and its receptor were downregulated in cerebral I/R group. This might be related to the decreasing number of regulatory T cells (Tregs).
Tregs are known to protect against ischemic stroke, prevent autoimmunity and modulate inflammation after cerebral I/R . However, kaempferol treatment has no significant effect to the IL-2 level in cerebral I/R rats.
Besides, protein array results showed the increasing MCP-1 and ICAM-1 could be significantly attenuated by kaempferol treatment. MCP-1 is a chemokine that regulate migration and infiltration of monocytes. ICAM-1 is an adhesion molecule promoting leukocyte trans-endothelial migration (Jin et al., 2013) . Both of two proteins promote immune cell across the brain blood barrier into ischemic tissue, releasing more proinflammation cytokines and exacerbating inflammatory response. Another important inflammatory biomakers, iNOS and COX-2 were also decreased by kaempferol. They were vastly secreted by microglia after being activated by reperfusion damage and
caused series of inflammatory response (Balami et al., 2013; Lambertsen et al., 2012 ).
In conclusion, kaempferol inhibited over-activation of microglia and expression of pro-inflammatory protein in cerebral I/R rats.
BBB integrity is important to function of nervous system (Zuo et al., 2019) .
However, many neurologic diseases such as stroke caused neuroinflammation, oxidative stress and apoptosis, which break the BBB integrity (Li et al., 2019) . In this study, we performed EB leakage experiment to test BBB integrity. The results showed EB leakage increased significantly in cerebral I/R rats and kaempferol decreased EB leakage into brain. From the result of the cytokine profile, we found the TIMP-1 expression increasing in I/R group and downregulated by kaempferol treatment.
TIMP-1 is natural inhibitors of MMPs and the balance between TIMP-1 and MMPs
plays an important role in inflammation (Eisner et al., 2017) . It has been reported that kaempferol could suppress expression of MMPs (especially for MMP-3) in LPSinduced microglia activation (Park et al., 2011) . Therefore, we measured the MMP-3 expression in cerebral I/R rats, data showed MMP-3 expression increased after I/R and was suppressed by kaempferol treatment. These results indicated kaempferol protected BBB integrity, which might be mediated by inhibiting MMP-3 expression.
NF-κB p65 is an essential transcription factor involved in many types of cellular process, phosphorylation of NF-κB p65 is required for NF-κB activation and promoting transcription factor activity (Diel et al., 2011; Oeckinghaus et al., 2011; Yang et al., 2019a) . NF-κB p65 was activated in ischemic hemisphere, as determined by increased expression of an NF-κB driven reporter transgene (Schneider et al., 1999) . Inhibiting NF-κB prior to MCAO protected ischemic cerebral tissue and reduced infarct size (Anttila et al., 2017) . Based on the information, pharmacological inhibition of NF-κB is a rational therapeutic target to diseases involved with NF-κB.
Kaempferol was reported to inhibit NF-κB activation in isoproterenol-induced heart failure in diabetic rats . However, the effect of kaempferol on NF-κB activation after ischemic stroke has not been reported. In this study, we investigated the mechanisms to attenuate neuroinflammation following kaempferol treatment and determined if NF-κB signal pathway was involved in the pathological processes after cerebral I/R. Since phosphorylation is a critical post-translational modification that regulates the activities of key components in NF-κB signaling
pathway, we performed Western blotting to verify the phosphorylation changes of NF-κB p65 and its inhibitory protein IκB on day 7 after surgery. Phosphorylation of NF-κB p65 was significantly reduced at treatment of 100mg/kg kaempferol, while kaempferol treatment has less effect on the phosphorylation of IκB. This demonstrated that kaempferol inhibited NF-κB pathway mainly from inhibiting phosphorylation of NF-κB p65. In additon, the effect of kaempferol on nuclear translocation of NF-κB p65 was also investigated in this study. The data showed kaempferol treatment significantly inhibited NF-κB p65 nuclear translocation after cerebral I/R. NF-κB p65 functions as a direct transcriptional activator in cell nuclear, it could also affect promoter accessibility to transcription factors and thereby indirectly regulate their gene expression. In conclusion, the results suggested that the inhibition of phosphorylation and nuclear translocation of NF-κB p65 is the one of the mechanisms of kaempferol to attenuate inflammation after cerebral I/R. This data is consistent with the studies that has shown transcription factor NF-κB p65 is involved in the regulation of inflammation response after stroke (Schneider et al., 1999) .
In our study, kaempferol was proved to be a potential therapeutic strategy to attenuate inflammation, reducing cerebral infarct volume and improving neurological outcome in experimental rat stroke model. Inhibiting NF-κB pathway might be key factor among the mechanisms of kaempferol protecting from brain tissue damage after I/R injury. However, the pathological processes are complicated during cerebral I/R, further studies are needed to explore the other signal pathways and investigate their interaction with NF-κB. In addition, the inflammatory response is very complicated and lasts months after stroke. Further studies are needed to evaluate kaempferol in a long term. The results obtaining from the current study provided useful evidences in developing kaempferol as a promising therapeutic drug to treat stroke patients, while the clinical effects have to be proved in the future. Sham group. According to a five-point scale used in the study (Yang, et al., 2003) , the rats exhibiting no neurological deficits (score 0) after 24 h reperfusion were considered not successfully established stroke models (2/75) and excluded from the experiments. The experiment design and using of each animal was shown in Fig. 8 . Kaempferol, purchased from Nanjing Zelang Biotechnology Co., Ltd., was prepared in saline containing 0.5% sodium carboxymethylcellulose (CMC-Na) and delivered by intragastric at dosed of 25, 50 and 100mg/kg body weight per day for 7 days, respectively. The rats in the sham group and I/R group were treated with the vehicle (0.5% CMC-Na in saline) in the same manner. Drug and vehicle were administered in a blinded fashion.
Material and methods

Animals and Experiment Design
J O U R N A L P R E -P R O O F JOURNAL PRE-J O U R N A L P R E -P R O O F
Neurological assessments and infarct volume evaluation
To evaluate the degree of stroke in each animal following the surgical procedure, neurological deficits assessments and brain infarct volume were evaluated.
Neurological deficits were assessed after kaempferol treatment using neurobehavioral test, which is graded on a five point scale as described in previous report (Yang, et al., 2003) : 0, no neurological deficits; 1, cannot extend left forelimb fully; 2, cannot walk straightly; 3, circle to the left; 4, inability to walk spontaneously or losing consciousness.
After neurological assessments, the rats were decapitated infarct volume analysis immediately. The brain tissues were dissected coronally into 2-mm slice using a scalpel. The sections were stained by 1% 2,3,5-tripenyltetrazolium chloride (TTC, Sigma, St. Louis, MO, USA) at 37 °C for 30 min, and then fixed in 4% paraformaldehyde at room temperature overnight prior to imaging. In the stained sections, the red region represents the viable tissues and the white area indicates the infarct tissue. The infarct area in each section were evaluated using the Image J/Fiji processing system (Schindelin, et al., 2012) . Infarct volume ratio=(The sum of infract area/ the sum of sections area)*100%.
Immunofluorescence detection of Iba-1
After kaempferol treatment, rats were anesthetized and perfused intracardially with PBS and then with 4% paraformaldehyde (PFA). Subsequently, the brain sections 
incubated for 5 min. After washing with flowing water for 10 min, cell nuclei was stained with DAPI (Servicebio technology) for 10 min. All images were acquired using fluorescence microscope (Eclipse C1, Nikon, Japan). Fluorescence intensity was analyzed using the image processing package Image J/Fiji (Schindelin, et al., 2012) . Cortices of ischemic hemispheres were defined to area to be analyzed and representative images were presented (3 rats in each group and 3 slides per rat).
Pro-inflammatory cytokine measurement by Multiplex Enzyme-linked Immunosorbent Assay
At the necropsy, the brain tissues were quickly removed and the cortices of ischemic hemispheres were dissected for frozen in liquid nitrogen. When conducting the experiment, the tissue samples were homogenized in PBS buffer and then centrifuged at 13,000 rpm at 4°C for 15 min. The supernatant was collected and the total amounts of protein were determined by BCA protein assay kit (Thermo, 
Analysis of cytokine profile by Protein Array assay
The supernatant of ischemic cortices was handled with the same procedure as Western blot, the amounts of protein were determined by BCA protein assay kit (Thermo, Rockford, USA). Then we conduct Protein Array assay (Cat#: QAR-CAA-67, RayBiotech, Norcross, GA) according to the manufacturer's instructions. Firstly, block each chip with blocking buffer for 30 minutes. Decant the buffer and add 50 ug samples to each well, incubating chips overnight at 4°C. Decant the sample and wash
by clusterProfiler database (R/Bioconductor).
Evans blue (EB) Leakage
At the day 7 after surgery, 4% Evans blue dye (Solarbio, Beijing, China) dissolved in 0.9% saline was injected (0.25ml/100g) into the tail vein of rats in each group. Two hours after injection, the rats were anesthetized and transcardially perfused with saline until the outflow fluid from the right atrium was clear. The brains were removed, dissected coronally into 2-mm and imaged. The ischemic hemispheres were collected immediately and homogenized in 50% trichloroacetic acid (100mg/300ul) and centrifuged at 13,000 rpm at 4°C for 5 min. The supernatant was collected and determined their optical density (OD) at 620 nm .
Isolation of proteins and Western blot analysis
At the end of study, the cortices of ischemic hemisphere were collected to examine the expression of iNOS and COX-2 in each group, phosphorylation of NF-κB p65 and IκB in Sham, I/R and I/R+KAE-100 treatment groups and also expression of MMP-3 in the three groups. Besides, the nuclear fraction and cytoplasmic fraction were extracted in Sham, I/R and I/R+KAE-100 groups with nuclear-cytosol extraction kit (Applygen Technologies Inc, Beijing, China) according to the manufacturer's instructions. Following the extraction, nuclear translocation of NF-κB p65 was measured in three groups. The cortices of ischemic brain tissue were mixed with RIPA buffer including cocktail protease inhibitor (100 mg/mL). Then the tissue was homogenized and centrifuged at 13000 rpm for 15 min. The supernatant was collected and mixed with loading buffer (Applygen Technologies Inc, Beijing, China) and heated at 100 ℃ for 10 min. Proteins were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and transferred to PVDF membrane.
The membrane was blocked with 5% BSA in Tris-buffered saline with Tween-20 (TBS-T) for 1 h and then incubated with anti-COX-2 antibody (ab15191, 1:1000), anti-iNOS antibody (ab204017, 1:500), anti-MMP-3 antibody (ab52915, 1:1000), anti-phospho NF-κB p65 antibody (CST#3033, 1:1000), anti-NF-κB p65 antibody (CST#8242, 1:1000), anti-phospho IκBα antibody (CST#2859, 1:1000), anti-IκBα antibody (CST#4814, 1:1000), anti-β-actin antibody (C1313, 1:1000) and anti-histone H3 antibody (orb136531, 1:1000) overnight at 4 °C, respectively. After washed with
TBS-T for 3 times, the membranes were incubated with secondary antibody for 2 h at room temperature and then detected using enhanced ECL system. Optical density values were analyzed using the ImageJ/Fiji processing system. The signal density of iNOS, COX-2 and NF-κB p65 in cytoplasm were normalized by total amount of internal β-actin protein. The signal density of NF-κB p65 in nuclear was normalized by total amount of histone H3. The signal density of phospho-NF-κB p65 and phospho-IκBα was normalized with total amount of NF-κB p65, IκBα, respectively.
Quantitative Real-Time PCR
Total RNA was extracted from the cortices of ischemic brain tissue using Trizol reagent (Ambion, Carlsbad, CA, USA) according to the manufacturer's instructions.
The concentration of RNA was measured by ultraviolet spectrophotometry .and determined using a formula A 260 * dilution * 40 = μg RNA/mL. The cDNA was synthesized using the PrimeScript™ RT reagent Kit (Takara Bio, Otsu, Japan). The primer sequences used to measure mRNA expression were listed as followings: method, the transcription expression of target genes of iNOS, and COX-2 was determined using GAPDH as internal reference. GAPDH was wildly reported as a reference gene and validated no change on the day 7 after I/R in our study.
Statistical Analysis
GraphPad Prism software version 7.04 (GraphPad Software, 7825 Fay Avenue, Suite
230 La Jolla, CA 92037 USA) was performed to compare the differences between each group. Data were presented as mean ± SEM. One-way ANOVA was used to calculate differences between the various groups. Tukey's multiple comparison post hoc test was performed to determine significance levels. Statistical significance was considered at p < 0.05. 
Highlights
 Kaempferol attenuates inflammation after cerebral ischemia reperfusion.  Kaempferol protects blood brain barrier integrity after cerebral ischemia reperfusion.  The anti-inflammatory mechanism of kaempferol might be mediated by NF-κB pathway.
